Longer undetectable hepatitis D RNA on bulevirtide predicts durable suppression off therapy, but rebound and ALT flares rise, especially in cirrhosis.
|Articles|April 1, 2000
Supplements and Featured Publications
- Asthma Management Alternatives for the New Millennium
- Volume 6
- Issue 7 Suppl
Adjunctive Therapy: Treatment Options
Author(s)Robert A. Nathan, MD
Advertisement
Articles in this issue
over 26 years ago
Participating Facultyover 26 years ago
Introductionover 26 years ago
The 1997 Asthma Guidelines and an Asthma Clinical Updateover 26 years ago
Discussion: Implementing the 1997 Asthma Guidelinesover 26 years ago
Overview of HEDIS 2000 Asthma Measurementover 26 years ago
Discussion: Using the HEDIS Asthma Measurementover 26 years ago
Discussion: The Impact of Allergens on Asthma Severity and Treatmentover 26 years ago
Discussion: Treatment Options for Asthmaover 26 years ago
Pharmacoeconomic Impact of Inhaled CorticosteroidsAdvertisement
Related to this article
Experts tackled CAR T access, trial equity, and overtreatment in breast cancer at an AJMC Institute for Value-Based Medicine event in San Francisco.
Systematic review finds combined immunonutrition (arginine, omega-3s, glutamine) in colorectal cancer surgery may cut surgical site infections, while single supplements show no benefit.
FACT Accreditation lets Tennessee Oncology bring community oncology CAR T-cell therapy closer to home, expanding access for non-Hodgkin lymphoma patients.
The analysis found a nonlinear association between systemic inflammation and overactive bladder, with stronger links at higher inflammation levels.
A real-world study found that adding a GLP-1 to SGLT2 inhibitor therapy was associated with lower kidney, cardiovascular, and mortality risks in CKD.
In experiments at MD Anderson, rising CD70 helps mantle cell lymphoma evade immunity; a CD70×CD3 bispecific restores T-cell killing and prolongs survival in resistant models.
The NPS index, ranging from –100 to +100, serves as a proxy for customers’ willingness to recommend products and services they themselves have used.
Advertisement
Advertisement
Trending on AJMC
1
Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices
2
Access and Innovation in North Carolina’s Research Triangle
3
Biomarker-Driven Care Is Racing Ahead of the Systems Built to Support It
4
Overcoming Barriers to Precision Care and Patient Access
5